Histopathology of the tissue adhering to the multiple tine expandable electrodes used for radiofrequency ablation of hepatocellular carcinoma predicts local recurrence

Internal Medicine

Volumn 51, Issue 19, 2012, Pages 2683-2688

  Ishikawa, Toru ^a   Kubota, Tomoyuki ^a   Abe, Hiroyuki ^a   Nagashima, Aiko ^a   Hirose, Kanae ^a   Togashi, Tadayuki ^a   Seki, Keiichi ^a   Honma, Terasu ^a   Yoshida, Toshiaki ^a   Kamimura, Tomoteru ^a   Nemoto, Takeo ^a   Takeda, Keiko ^a   Ishihara, Noriko ^a  

^a Saiseikai Niigata Daini Hospital   (Japan)

Author keywords

Electrode; Hepatocellular carcinoma; Local recurrence; Radiofrequency ablation; Viable tissue

Indexed keywords

CILASTATIN PLUS IMIPENEM; KI 67 ANTIGEN;

AGED; ARTICLE; CANCER RECURRENCE; CELL VIABILITY; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; ELECTRODE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NECROSIS; OVERALL SURVIVAL; PREDICTION; PULSE OXIMETRY; RADIOFREQUENCY ABLATION; RECURRENCE RISK; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; ELECTRODES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NECROSIS; NEOPLASM RECURRENCE, LOCAL; TISSUE ADHESIONS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84867809969     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.7779     Document Type: Article

References (30)

1. Shariff MI, Cox IJ, Gomaa AI, Khan SA, Gedroyc W, Taylor-Robinson SD. Hepatocellular carcinoma: current trends in world-wide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev Gastroenterol Hepatol 3: 353-367, 2009.
2. Mazzaferro V, Romito R, Schiavo M, et al. HCC Italian Task Force. Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis. Hepatology 44: 1543-1554, 2006.
3. Ferenci P, Fried M, Labrecque D, et al. World Gastroenterology Organization. Hepatocellular carcinoma (HCC): a global perspec-tive. J Clin Gastroenterol 44: 239-245, 2010.
4. Fan ST, Lo CM, Liu CL, et al. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 229: 322-330, 1999.
5. Mor E, Kaspa RT, Sheiner P, Schwartz M. Treatment of hepato-cellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med 129: 643-653, 1998.
6. Befeler AS, Hayashi PH, Di Bisceglie AM. Liver transplantation for hepatocellular carcinoma. Gastroenterology 128: 1752-1764, 2005.
7. Rossi S, Fornari F, Buscarini L. Percutaneous ultrasound guided radiofrequency electrocautery for the treatment of small hepatocel-lular carcinoma. J Interv Radiol 8: 97-103, 1993.
8. Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of un-resectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 230: 1-8, 1999.
9. Buscarini E, Savoia A, Brambilla G, et al. Radiofrequency thermal ablation of liver tumors. Eur Radiol 15: 884-894, 2005.
10. Harrison LE, Koneru B, Baramipour P, et al. Locoregional recur-rences are frequent after radiofrequency ablation for hepatocellular carcinoma. J Am Coll Surg 197: 759-764, 2003.
11. Guglielmi A, Ruzzenente A, Battocchia A, Tonon A, Fracastoro G, Cordiano C. Radiofrequency ablation of hepatocellular carcinoma in cirrhotic patients. Hepatogastroenterology 50: 480-484, 2003.
12. Nakazawa T, Kokubu S, Shibuya A, et al. Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor pro-gression after ablation and ablative margin. Am J Roentgenol 188: 480-488, 2007.
13. Coad JE, Kosari K, Humar A, Sielaff TD. Radiofrequency abla-tion causes 'thermal fixation' of hepatocellular carcinoma: a post-liver transplant histopathologic study. Clin Transplant 17: 377-384, 2003.
14. Morimoto M, Sugimori K, Shirato K, et al. Treatment of hepato-cellular carcinoma with radiofrequency ablation: radiologic-histologic correlation during follow-up periods. Hepatology 35: 1467-1475, 2002.
15. Goldberg SN, Grassi CJ, Cardella JF, et al. Society of Interven-tional Radiology Technology Assessment Committee; International Working Group on Image-Guided Tumor Ablation. International Working Group on Image-Guided Tumor Ablation. Radiology 235: 728-739, 2005.
16. Kaplan EL, Meier P. Nonparametirc estimation for incomplete ob-servation. J Am Stat Assoc 53: 457-481, 1958.
17. Rossi S, Fornari F, Paties C, Buscarini L. Thermal lesions induced by 480 KHz localized current field in guinea pig and pig livers. Tumori 76: 54-57, 1990.
18. McGahan JP, Browning PD, Brock JM, Tesluk H. Hepatic abla-tion using radiofrequency electrocautery. Invest Radiol 25: 267-272, 1990.
19. Lencioni RA, Allgaier HP, Cioni D, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 228: 235-240, 2003.
20. Shiina S, Teratani T, Obi S, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocel-lular carcinoma. Gastroenterology 129: 122-130, 2005.
21. Horiike N, Iuchi H, Ninomiya T, et al. Influencing factors for re-currence of hepatocellular carcinoma treated with radiofrequency ablation. Oncol Rep 9: 1059-1062, 2002.
22. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Randomised con-trolled trial comparing percutaneous radiofrequency thermal abla-tion, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 54: 1151-1156, 2005.
23. Harrison LE, Koneru B, Baramipour P, et al. Locoregional recur-rences are frequent after radiofrequency ablation for hepatocellular carcinoma. J Am Coll Surg 197: 759-764, 2003.
24. Pulvirenti A, Garbagnati F, Regalia E, et al. Experience with ra-diofrequency ablation of small hepatocellular carcinomas before liver transplantation. Transplant Proc 33: 1516-1517, 2001.
25. Rossi S, Garbagnati F, Lencioni R, et al. Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carci-noma after occlusion of tumor blood supply. Radiology 217: 119-126, 2000.
26. Sugimori K, Morimoto M, Shirato K, et al. Radiofrequency abla-tion in a pig liver model: effect of transcatheter arterial emboliza-tion on coagulation diameter and histologic characteristics. Hepa-tol Res 24: 164, 2002.
27. Sofocleous CT, Klein KM, Hubbi B, et al. Histopathologic evalu-ation of tissue extracted on the radiofrequency probe after ablation of liver tumors: preliminary findings. Am J Roentgenol 183: 209-213, 2004.
28. Yu HC, Cheng JS, Lai KH, et al. Factors for early tumor recur-rence of single small hepatocellular carcinoma after percutaneous radiofrequency ablation therapy. World J Gastroenterol 11: 1439-1444, 2005.
29. Hori T, Nagata K, Hasuike S, et al. Risk factors for the local re-currence of hepatocellular carcinoma after a single session of per-cutaneous radiofrequency ablation. J Gastroenterol 38: 977-981, 2003.
30. Komorizono Y, Oketani M, Sako K, et al. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency abla-tion. Cancer 97: 1253-1262, 2003.